Published online Jun 6, 2020. doi: 10.12998/wjcc.v8.i11.2387
Peer-review started: March 2, 2020
First decision: April 22, 2020
Revised: May 9, 2020
Accepted: May 16, 2020
Article in press: May 16, 2020
Published online: June 6, 2020
Processing time: 97 Days and 20.9 Hours
Ataxia-telangiectasia (AT) is a rare, autosomal recessive, multisystem disorder. Because most clinicians have low awareness of the disease, only scarce reports of AT exist in the literature, especially of cases with lymphoma/leukemia.
A 7-year-old girl with a history of recurrent respiratory tract infections was referred to our department because of unstable walking for 5 years and enlarged neck nodes for 2-mo duration. Physical examination revealed scleral telangiectasia and cerebellar ataxia. Elevated alpha-fetoprotein, decreased serum immunoglobulin, and decreased T cell function were the major findings of laboratory examination. Histological analysis of cervical lymph node biopsy was suggestive of classical Hodgkin's lymphoma. Genetic examination showed heterozygous nucleotide variation of c.6679C>T and heterozygous nucleotide variation of c.5773 delG in the ATM gene; her parents were heterozygotes. The final diagnosis was AT with Hodgkin's lymphoma.
Clinicians should strengthen their understanding of AT diseases. Gene diagnosis plays an important role in its diagnosis and treatment.
Core tip: Ataxia-telangiectasia (AT) is a rare, autosomal recessive, multisystem disorder. Homozygous or compound heterozygous mutations of the ATM gene is the pathogenic factor and there is no specific treatment for AT. Through this study of a case of AT complicated with Hodgkin's lymphoma, it is suggested that clinicians should strengthen their understanding of AT diseases.